David M Ross - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

David M Ross

Showing results (121-130 of 130) with videos related to

Pageof 13

Sort By:

You have reached the last page of results.This site can display upto 130 results.

Leukemia|August 30, 2022

Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patientsBarbara Mora, Paola Guglielmelli, Andrew Kuykendall, et al.

Blood|April 20, 2022

Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor resistance in acute myeloid leukemiaAlexander C Lewis, Victoria S Pope, Melinda N Tea, et al.

Internal Medicine Journal|May 28, 2021

COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statementGeorgia McCaughan, Pietro Di Ciaccio, Michelle Ananda-Rajah, et al.

Blood|July 4, 2018

Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk diseaseSusan Branford, Paul Wang, David T Yeung, et al.

The New England Journal of Medicine|December 12, 2019

Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor FailureTimothy P Hughes, Michael J Mauro, Jorge E Cortes, et al.

Blood|March 5, 2026

Genomic profiling for decision-making in post-polycythemia vera and post-essential thrombocythemia myelofibrosisBarbara Mora, Francesca Palandri, Paola Guglielmelli, et al.

Blood|December 27, 2022

TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtypeDevendra Hiwase, Christopher Hahn, Elizabeth Ngoc Hoa Tran, et al.

Blood|September 21, 2022

Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemiaEric J Duncavage, Adam Bagg, Robert P Hasserjian, et al.

Blood Advances|April 25, 2024

Unraveling facets of MECOM-associated syndrome: somatic genetic rescue, clonal hematopoiesis, and phenotype expansionParvathy Venugopal, Peer Arts, Lucy C Fox, et al.

Blood|July 11, 2024

Germ line ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predispositionJiarna R Zerella, Claire C Homan, Peer Arts, et al.

Pageof 13

Search research articles

Showing results (121-130 of 130) with videos related to

Sort By:

Pageof 13

You have reached the last page of results.This site can display upto 130 results.

Leukemia|August 30, 2022

Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patientsBarbara Mora, Paola Guglielmelli, Andrew Kuykendall, et al.

Blood|April 20, 2022

Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor resistance in acute myeloid leukemiaAlexander C Lewis, Victoria S Pope, Melinda N Tea, et al.

Internal Medicine Journal|May 28, 2021

COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statementGeorgia McCaughan, Pietro Di Ciaccio, Michelle Ananda-Rajah, et al.

Blood|July 4, 2018

Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk diseaseSusan Branford, Paul Wang, David T Yeung, et al.

The New England Journal of Medicine|December 12, 2019

Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor FailureTimothy P Hughes, Michael J Mauro, Jorge E Cortes, et al.

Blood|March 5, 2026

Genomic profiling for decision-making in post-polycythemia vera and post-essential thrombocythemia myelofibrosisBarbara Mora, Francesca Palandri, Paola Guglielmelli, et al.

Blood|December 27, 2022

TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtypeDevendra Hiwase, Christopher Hahn, Elizabeth Ngoc Hoa Tran, et al.

Blood|September 21, 2022

Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemiaEric J Duncavage, Adam Bagg, Robert P Hasserjian, et al.

Blood Advances|April 25, 2024

Unraveling facets of MECOM-associated syndrome: somatic genetic rescue, clonal hematopoiesis, and phenotype expansionParvathy Venugopal, Peer Arts, Lucy C Fox, et al.

Blood|July 11, 2024

Germ line ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predispositionJiarna R Zerella, Claire C Homan, Peer Arts, et al.

Pageof 13